Schayowitz Adam insider trades
Schayowitz Adam has filed 3 Form 4s with the SEC that we hold, for Zymeworks Inc. (ZYME) (EVP, Head of R&D) and Faeth Therapeutics, Inc. (FTH) (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $357.6K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($357.6K). The largest single trade was a sale of 13,832 shares of Zymeworks Inc. worth $357.6K, dated 2026-10-09. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2026-04-10 and the latest 2026-10-27.
Zymeworks Inc. (ZYME)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-10-09 | S, sale reported on Form 4 | 13,832 | $357.6K | 2026-10-09 | SEC |
Faeth Therapeutics, Inc. (FTH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 2127119) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
